Search Results

Fusion for Energy completes full delivery of ITER cryopump distribution system

The International Thermonuclear Experimental Reactor (ITER) will operate in an ultra-high vacuum environment. To prevent contamination inside the device, a set of cryopumps supplied by Europe will extract gas particles and alternate operation before and after plasma discharges, maintaining the vacuum vessel pressure at approximately one millionth of Earth's atmospheric pressure. The core of cryopump operation lies in the extremely low-temperature environment. Its internal panels will be cooled to 4 K, approximately minus 269 degrees Celsius, close to absolute zero, to capture gas particles; they are then warmed to release and expel the particles. To precisely control this process, Europe is also supplying ITER with the Front-End Cryopump Distribution System (FECDS), which delivers helium at specific doses and temperatures to the cryopumps...

2026-08-12

UK Low-Level Waste Repository Advances Capping Project, Rail-Transported Aggregate Exceeds 285,000 Tonnes

Nuclear Waste Services (NWS) is advancing capping-related works at the Low-Level Waste Repository on the west coast of Cumbria, UK, to strengthen long-term protection of existing disposal trenches and vaults. Since the repository began operations in 1959, it has supported the safe disposal of approximately 1 million cubic metres of low-level radioactive waste, making it a key facility in the UK's radioactive waste management system. NWS, part of the Nuclear Decommissioning Authority (NDA), is primarily responsible for consolidating the UK's radioactive waste management capabilities, providing management solutions for legacy wastes from civil and defence sectors as well as wastes arising from future new-build nuclear projects...

2026-08-12

Fuse Energy Technologies Corp. Reports FAETON-X Single-Shot D-D Fusion Neutron Yield of 1.27×10¹²

Fuse Energy Technologies Corp., headquartered in California, USA, announced on August 11 that its megajoule-class dense plasma focus device FAETON-X measured a peak neutron yield of (1.27±0.27)×10¹² neutrons per shot in a single D-D fusion experiment. The company stated that this is one of the highest single-shot fusion neutron yields publicly recorded by a commercial fusion enterprise, and the first to reach the 10¹² order of magnitude. FAETON-X is a megajoule-class pulsed-power fusion system developed by Fuse, designed as a single-pulse flash neutron source, serving pulsed-power fusion R&D and...

2026-08-12

Kazakhstan's National Nuclear Center Advances Material Testing Research for Future Reactors

On August 11, the National Nuclear Center of the Republic of Kazakhstan presented its progress in research on structural materials for advanced reactors. Yerzhan Ernatuly Sapataev, head of the Radiation Materials Science Laboratory at the center's Institute of Atomic Energy, stated that the development of next-generation reactors and fusion technologies has imposed higher requirements on structural materials in terms of high-temperature resistance, radiation tolerance, and corrosion resistance, and that material reliability will directly determine the safety and service life of future nuclear energy systems. Materials inside future reactors typically need to...

2026-08-12

Two Units of Kozloduy NPP Operating at Full Capacity as Scheduled

As of 13:00 on August 11, 2026, the two units of Kozloduy Nuclear Power Plant continue to operate at full capacity in accordance with the power generation schedule. The plant's operating team maintains continuous watch to ensure the safe and stable operation of the relevant facilities. To guarantee the water volume required for the circulating pump station and the technical water cooling system, the plant has implemented technical and organizational measures under existing conditions to maintain the operation of the shore pump station. The technical condition of the relevant facilities requires ongoing attention, and operational parameters are being continuously monitored on site. To optimize water intake conditions, the plant needs to clean the riverbed between the Danube River and the shore pump station. The operation of the shore pumps is being monitored, with flow regulated by adjusting the blade angles; if necessary, further...

2026-08-12

TRISO-X and Oak Ridge National Laboratory Extend Advanced Nuclear Fuel R&D Collaboration

TRISO-X announced on August 11 that it has extended its Collaborative Research and Development Agreement with the U.S. Department of Energy's Oak Ridge National Laboratory (ORNL). The newly signed agreement has a term of 30 months and will continue to advance commercial-scale development of TRISO fuel, manufacturing process optimization, and technology transfer, building on the collaboration established since 2016. TRISO-X is a wholly-owned subsidiary of X-energy, primarily engaged in advanced nuclear fuel manufacturing. Under the agreement, TRISO-X will continue to operate its existing pilot-scale facilities at Oak Ridge National Laboratory, with a focus on transitioning TRISO fuel from laboratory R&D to commercial-scale manufacturing. The collaboration includes optimizing fuel...

2026-08-12

Leshan Accelerates Construction of Medical Isotope Production Base to Promote Domestic Substitution of "Anti-Cancer Nuclear Drugs"

On August 11, at the Leshan special press conference of "Myriad Scenes in Sichuan · Embarking on the '15th Five-Year Plan'", Leshan Mayor Zhao Yingchun stated that Leshan is accelerating the construction of the largest and most comprehensive medical isotope production base in China. Upon completion, the project will help break the foreign monopoly and import dependence on related products, promote the domestic substitution of anti-cancer nuclear drugs, and enable more patients to access domestically produced drugs with lower prices and better efficacy. Zhao Yingchun noted that during the "14th Five-Year Plan" period, Leshan has focused on building the "China Green Silicon Valley", a world-class tourist destination, and a major regional transportation and logistics hub in the province, continuously promoting high-quality development, with its economic output surpassing 250 billion yuan...

2026-08-12

Chinese Team Proposes "Toxic Blood Meal" Pre-Treatment Approach to Boost Sterile Insect Technique for Mosquitoes

Chinese researchers have recently proposed a novel sex-sorting approach for the Sterile Insect Technique (SIT) in mosquitoes: adding a specific agent to the blood meal ingested by female mosquitoes, leveraging the biological difference that female mosquitoes feed on blood while males do not, to substantially reduce the number of females before release. The study was published in the June issue of the Journal of Medical Entomology. The Sterile Insect Technique is a pest population control method centered on radiation-induced sterility. Its basic process involves mass-rearing male target insects in the laboratory, sterilizing them through radiation exposure to render them reproductively incapable, and then releasing them into the field, where they mate with wild females to produce non-viable eggs, thereby suppressing target population growth. This technique has been incorporated into integrated pest management systems and is regarded as a relatively environmentally friendly pest control approach.

2026-08-12

Texas to Accelerate Opening of Sterile Fly Facility to Combat New World Screwworm Outbreak

The U.S. Department of Agriculture announced that, in response to the New World screwworm (NWS) outbreak already detected in Texas and New Mexico, the sterile fly facility at Moore Air Base in Edinburg, Texas, will open early next spring, approximately seven months ahead of the original schedule. Construction on the facility began in April of this year, and once completed, it will produce sterile flies to support outbreak control efforts using the Sterile Insect Technique (SIT). Under the plan, the facility will reach full operational capacity by the end of 2028, producing approximately 300 million sterile flies per week. The Sterile Insect Technique works by releasing sterilized flies into the environment to mate with wild screwworms, thereby interrupting the reproductive cycle and reducing the risk of continued parasite spread...

2026-08-12

French city of Illkirch plans to test sterile insect technique to combat tiger mosquitoes

Thibaud Philipps, Mayor of Illkirch-Graffenstaden in France's Bas-Rhin department, hopes to pilot the Sterile Insect Technique (SIT/TIS) locally, sterilizing male tiger mosquitoes through radiation and releasing them regularly to curb population growth. According to local authorities, tiger mosquitoes have been officially established in Illkirch-Graffenstaden since 2019. In recent years, the local tiger mosquito population has continued to increase, significantly impacting residents' daily lives. The municipal government has previously implemented multiple control measures, including launching the "Tiger Team" project in 2024 to educate the public on mosquito prevention and control methods, as well as providing subsidies of up to 50 euros per household for purchasing mosquito traps. To date, approximately 400 households have received relevant traps...

2026-08-12

University of Tokyo and University of York Successfully Validate Positronium Ratio Imaging Principle for the First Time

A research team from the Graduate School of Engineering at the University of Tokyo and the University of York in the UK established a novel geometric imaging principle utilizing positron three-photon decay. Using a gamma-ray measurement system comprising scintillators and silicon photomultipliers (SiPMs), along with the existing PET radiopharmaceutical ^18F-FDG, they successfully visualized the positronium three-photon decay ratio for the first time, completing the proof-of-principle for Positronium Ratio Imaging (PRI). The findings were published in *Communications Physics*. Current clinical nuclear medicine PET examinations primarily utilize gamma rays generated from two-photon annihilation between positrons and electrons to visualize drug accumulation in the body. While this method provides quantitative information on metabolism or drug uptake, it offers limited insight into microenvironmental features such as tissue hypoxia, which are closely related to disease malignancy. In recent years, researchers have attempted to obtain additional tissue information through the average lifetime of positronium formed during positron annihilation, but this approach typically requires the introduction of special nuclides or agents, limiting its practical application.

2026-08-12

Korea Fusion Energy Institute Launches Design and Manufacturing of ITER Tritium Storage and Supply Vessels

The Korea Fusion Energy Institute (KFE) announced on August 12 at its headquarters in Daejeon that it has signed a contract with a consortium comprising Iljin Power and Aizen Core to undertake the design and manufacturing of the tritium storage and supply vessels for the International Thermonuclear Experimental Reactor (ITER). ITER is currently the world's largest fusion experimental device, being jointly constructed by seven parties—Korea, the United States, the European Union, Japan, China, Russia, and India—in Cadarache, southern France. Under the procurement agreement signed between KFE and the ITER Organization in March 2025, Korea...

2026-08-12

LG Electronics Launches FDA-Approved 40-Inch Diagnostic Monitor for B2B Medical Imaging Market

LG Electronics announced on August 12 that it has launched a new 40-inch diagnostic monitor, the 40HT513D, targeting the business-to-business (B2B) medical display market. The product has received approval from the U.S. Food and Drug Administration (FDA) and is primarily intended for medical image interpretation. According to the company, the 40HT513D features a curved IPS black panel with a 21:9 aspect ratio and a resolution of 5120×2160, delivering approximately 11 million pixels. LG Electronics stated that this design consolidates image reading tasks that previously required three 3-megapixel monitors into a single screen. Physicians can simultaneously view and compare current and historical images from X-ray, CT scans, and MRI scans on the same display...

2026-08-12

China Bio-Pharma: Enters Cooperation Agreement with Stella Pharma on Boron Neutron Therapy Drug

China Bio-Pharma Holdings Limited announced on August 12 that the company, Pengbo (Hainan) Boron Neutron Medical Technology Co., Ltd., and Japan's Stella Pharma Corporation signed a legally binding Master Cooperation Agreement on August 11, 2026, to jointly advance the development and commercialization of Steboronine in China. Steboronine is described in the announcement as the world's first approved boron neutron therapy drug, applied in Boron Neutron Capture Therapy (BNCT). Under the agreement, the cooperation between the two parties is divided into a development phase and a commercialization phase. During the development phase, the cooperation aims to leverage real-world data, real-world evidence, and real-world studies generated by the China Bio-Pharma Group to facilitate Stella Pharma in obtaining and maintaining, as soon as possible, marketing approval from China's National Medical Products Administration (NMPA) for Steboronine for the treatment of head and neck cancer; after Stella Pharma obtains marketing and manufacturing approval from the Japanese government for Steboronine for meningioma, the relevant China filings may also be extended to the meningioma indication.

2026-08-12

University of Missouri Receives $1 Million Grant to Research New FLASH Radiotherapy System

On August 11, researchers at the University of Missouri School of Medicine received a $1 million grant from the National Institutes of Health to study a new technology in cancer radiotherapy—the TheryQ FLASHKNiFE system. The project is funded through June 2027. A long-standing challenge in cancer treatment is how to kill tumor cells while protecting surrounding healthy tissue as much as possible. Existing radiotherapy can already achieve millimeter-level precision, but radiation damage and related side effects still limit the dose patients can safely receive. Unlike conventional approaches, FLASH radiotherapy does not primarily alter the direction of radiation beams, but instead delivers irradiation in an extremely short time at an ultra-high dose rate...

2026-08-12